Fierce Drug Dev Forum 2019 has ended

Create Your Own Event

Fierce Drug Dev Forum 2019

7:30am PDT

Main Conference Registration and Continental Breakfast

8:30am PDT

Chairperson’s Opening Remarks

8:45am PDT

Keynote: Fireside Chat with Teresa Bitetti, President, Global Oncology, TAKEDA ONCOLOGY

9:15am PDT

Prioritize, Consolidate, and Refine R&D Investment Through Strategic Portfolio/Pipeline Planning to Deliver the Greatest Overall Value to Your Company and Shareholders

10:00am PDT

Networking Break

10:30am PDT

Build Vs. Buy: Key Considerations for Deciding Whether to Commercialize on Your Own or Find a Strategic Partner

11:15am PDT

Uncertainty, Challenges, and Implications of Today’s Reimbursement Environment on the Deal-Making Landscape and Beyond

12:00pm PDT

Luncheon

1:00pm PDT

Track Chair Opening Remarks Track Chair Opening Remarks

1:15pm PDT

Key Questions Small Companies Should Ask When Evaluating Potential Partners Amgen’s Approach to Designing Clinical Trials That Can Improve the Rate of Success

2:00pm PDT

Buy-Side BD&L: Insights Into Process and Decision- Making at Big Pharma/Big Biotech Explore How AI and Machine Learning Can Be the Backbone to Building a Hypothesis for Drug Discovery

2:45pm PDT

Networking Break

3:15pm PDT

Case Study: Key Considerations When Evaluating AI Capabilities and Non-Molecule Driven Targets for Acquisition New Indications in the Approval of Medicines

4:00pm PDT

Consider the Risk Profile Associated With Different Sources and Mechanisms of Financing Find Drivers for Development Success: IND Through Clinical Proof-of-Concept

4:45pm PDT

Case Study: Living with the Deal - Managing the Legend Biotech and Janssen Global CAR-T Collaboration Preparing for Commercialization and Transactional Success

5:30pm PDT

Cocktail Networking Reception and Fierce15 Awards

6:30pm PDT

Day One Concludes

8:00am PDT

Continental Breakfast

8:45am PDT

Recap of Day One Recap of Day One

9:00am PDT

From Big to Small: How to Transition From Big Companies and Successfully Drive BD at a Start-Up Company How Small Companies Can Build and Leverage Outside Resources for Smarter Drug Development When Working With a Limited Budget

9:45am PDT

Explore Innovative Deal Constructs and Risk-Sharing Structures for Licensing and Acquisition Deals Getting Real: The Changing Tide on Real-World Evidence in Drug Development

10:30am PDT

Networking Break

11:00am PDT

Compare and Contrast Different Operating Models for Search and Evaluation to Advance Innovation Leverage Innovative Regulatory Pathways to Expedite Drug Development

11:45am PDT

Different Approaches to Retaining Key Talent Post- Transaction Develop a Go-To-Market and Launch Strategy That Successfully Differentiates Your Launch Providing the Best Possible Access for Patients

12:30pm PDT

Luncheon

1:30pm PDT

Bringing a Novel Therapy to Market: Lessons from the Front Lines

1:45pm PDT

Emerging Market Access to Affordable Medicine

2:30pm PDT

Conference Concludes